Polycystic Ovary Syndrome
Conditions
Brief summary
In 1935 the polycystic ovary syndrome was a clinical diagnosis made on the morphological appearance of the ovaries in association with amenorrhoea, hirsutism and frequently obesity. At that time wedge resection of the ovaries was introduced on an empirical basis and proved a successful treatment for the associated anovulation and infertility. In the ensuing fifty years the limitations of a purely surgical approach to therapy have become recognized and the importance of the biochemical abnormalities appreciated. Prevalence of polycystic Ovary Syndrome: The prevalence of polycystic ovary syndrome in any specified population is dependent upon the diagnostic criteria used, but does have some regional and ethnic variation. While most reports on the prevalence of polycystic ovary syndrome range between 2 and 20%, the chosen diagnostic criteria are recognized to influence the determined prevalence. Anti-mullerian hormone which is a predictor of ovarian reserve is known to decrease after laparoscopic ovarian drilling. On the best of our knowledge no study had been done to use the level of anti-mullerian hormone as a factor for planning the number of ovarian drills in each ovary.
Interventions
PROCEDURELaparoscopic ovarian drilling
The electric current used was set at 40 Watts. The power was activated just before touching the ovary, and then the needle electrode was held against the antimesenteric surface of the ovary for 4 seconds until penetration of the ovarian capsule. Four or eight puncture points were made through the ovarian capsule of each ovary according to the study protocol. The ovaries were cooled in the pool of the Ringer's lactate after each cauterization both to minimize adhesion formation and to prevent heat trauma to the adjacent viscera. Complete hemostasis was ensured. At the end of the procedure, the ovaries were copiously rinsed with Ringer's lactate (Aqua-purator, Storz, Germany). An amount about 200 ml of heparinized Ringers lactate (5000 IU/1000 ml) was left in the pelvis to avoid postoperative adhesions.
BIOLOGICALAntimullerian hormone
1. In patients with Antimullerian hormone between 4-8 ng/ml 4 punctures in each ovary were performed. 2. In patients with Antimullerian hormone above 8 ng/ml 8 punctures in each ovary were performed.
Sponsors
Assiut University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No
Inclusion criteria
1. Infertility more than 2 years. 2. Age between 20-35 years. 3. clomiphene resistant patients: Patients received clomiphene 150 mg from day 3 to 7 of the menstrual cycle for 6 months and non-ovulatory (with failure of conception). They were followed up in the outpatient clinic. 4. No contraindications for laparoscopy. 5. Normal Hysterosalpingography
Exclusion criteria
1. Contraindications for laparoscopy e.g cardiac diseases, bad scared abdomen ect…. 2. Women's age less than 20 years or more than 35 years. 3. Previous Laparoscopic surgery. 4. Previous ovarian surgery. 5. Women with Antimullerian hormone level less than 4 ng/ml. 6. Tubal factor infertility as diagnosed by Hysterosalpingography .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size of ovarian follicle (mm) | 14 days |
Secondary
| Measure | Time frame |
|---|---|
| Antimullerian hormone level (ng/dl) | 3 months |
| Ovarian volume (ml) | 3 months |
Countries
Egypt
Outcome results
None listed